FD&C Red 3


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1017 CDK2 Increases activity PMID:8927716; PMID:9168006
1576 CYP3A4 Decreases activity PMID:20041016
1588 CYP19A1 Decreases activity PMID:18310892
213 ALB Increases expression PMID:39843243
2237 FEN1 Decreases expression PMID:28893156
27306 HPGDS Decreases activity PMID:25603235
2875 GPT Increases expression PMID:39843243
3725 JUN Increases expression PMID:20025956
389434 IYD Decreases activity PMID:24012475
43 ACHE Increases activity PMID:39400474; PMID:39600142; PMID:39843243
5004 ORM1 Increases expression PMID:20025956
51455 REV1 Decreases expression PMID:28893156
5243 ABCB1 Decreases activity PMID:20041016
5251 PHEX Increases expression PMID:20025956
54578 UGT1A6 Decreases activity PMID:20041016
595 CCND1 Increases expression PMID:8927716
7157 TP53 Increases activity PMID:9168006
7252 TSHB Increases expression PMID:2447681
7364 UGT2B7 Decreases activity PMID:20041016
7422 VEGFA Increases expression PMID:20025956
8061 FOSL1 Increases expression PMID:20025956
847 CAT Decreases activity PMID:39400474; PMID:39843243

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.